
Chennai Meenakshi Multispeciality Hospital Faces Intense Selling Pressure Amid Market Volatility
2025-12-04 11:41:22Chennai Meenakshi Multispeciality Hospital has encountered significant selling pressure in recent trading sessions, with the stock registering no buying interest and only sell orders queued. This unusual market behaviour signals distress selling and raises concerns about investor sentiment towards the healthcare services provider.
Read More
Chennai Meenakshi Multispeciality Hospital Sees Unprecedented Buying Interest Amid Upper Circuit
2025-11-27 13:40:11Chennai Meenakshi Multispeciality Hospital has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals strong investor enthusiasm and the potential for a multi-day circuit scenario, setting the healthcare services stock apart amid mixed sector and benchmark performances.
Read More
Chennai Meenakshi Multispeciality Hospital Sees Extraordinary Buying Interest Amid Upper Circuit Scenario
2025-11-24 09:55:11Chennai Meenakshi Multispeciality Hospital has attracted remarkable buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility and sector underperformance.
Read MoreWhy is Chennai Meena falling/rising?
2025-11-21 00:10:05Short-Term Price Movement and Market Sentiment The stock opened sharply lower, registering an opening gap down of approximately 5%, which set the tone for the day’s trading session. Intraday volatility was relatively contained, with the share price fluctuating within a narrow range of just ₹0.18 and touching a low of ₹43.32, close to the day’s close. This limited price movement suggests that while selling pressure was evident, it was not accompanied by extreme volatility, indicating measured investor reactions rather than panic selling. Notably, the stock underperformed its sector by 4.62% on the day, highlighting a relative weakness compared to peers. This underperformance is further underscored by the stock’s failure to trade on one of the last 20 trading days, point...
Read More
Chennai Meenakshi Multispeciality Hospital Sees Upper Circuit with Only Buy Orders in Queue
2025-11-19 12:35:10Chennai Meenakshi Multispeciality Hospital Ltd has entered an extraordinary phase of market activity, registering an upper circuit scenario characterised by exclusively buy orders in the queue. This rare event highlights intense buying interest with no sellers willing to part with shares, signalling a potential multi-day circuit situation for the healthcare services stock.
Read More
Chennai Meenakshi Multispeciality Hospital Q2 FY26: Return to Profitability Amid Persistent Structural Challenges
2025-11-15 09:21:33Chennai Meenakshi Multispeciality Hospital Ltd., a 105-bed healthcare facility based in Chennai's Mylapore neighbourhood, reported a return to quarterly profitability in Q2 FY26 with net profit of ₹0.15 crores, marking a sharp reversal from the ₹0.74 crore loss posted in the preceding quarter. However, this modest turnaround does little to mask the company's deep-rooted financial distress, characterised by negative shareholder equity of ₹1.89 crores, persistent operational volatility, and a market capitalisation that has shrunk to just ₹37.00 crores.
Read MoreHow has been the historical performance of Chennai Meena?
2025-11-14 23:40:15Answer: The historical performance of Chennai Meena shows a fluctuating trend in its financial metrics over the years. Breakdown: Chennai Meena's net sales decreased from 38.74 Cr in Mar'23 to 34.82 Cr in Mar'25, reflecting a decline in revenue. The total operating income followed a similar trend, dropping from 38.74 Cr in Mar'23 to 34.82 Cr in Mar'25. The company experienced an operating profit (PBDIT) decline, moving from 3.35 Cr in Mar'23 to a loss of 0.21 Cr in Mar'25. Consequently, the profit before tax also fell from 1.28 Cr in Mar'23 to a loss of 1.43 Cr in Mar'25, leading to a profit after tax decline from 0.89 Cr to a loss of 1.37 Cr in the same period. The company's total liabilities remained relatively stable, with a slight decrease from 22.81 Cr in Mar'24 to 22.51 Cr in Mar'25. Cash flow from operating activities remained consistent at 2.00 Cr from Mar'22 to Mar'25, while the closing cash and c...
Read MoreHow has been the historical performance of Chennai Meena?
2025-11-13 23:17:48Answer: The historical performance of Chennai Meena shows a fluctuating trend in its financial metrics over the years. Breakdown: Chennai Meena's net sales have seen a decline from INR 38.74 crore in March 2023 to INR 34.82 crore in March 2025, following a peak of INR 38.20 crore in March 2024. The total operating income mirrored this trend, decreasing from INR 38.74 crore in March 2023 to INR 34.82 crore in March 2025. The company's operating profit (PBDIT) has also deteriorated, moving from INR 3.35 crore in March 2023 to a loss of INR 0.21 crore in March 2025. Consequently, the profit before tax shifted from a positive INR 1.28 crore in March 2023 to a loss of INR 1.43 crore in March 2025, and the profit after tax reflected a similar decline, going from INR 0.89 crore to a loss of INR 1.37 crore in the same period. The company's total liabilities slightly decreased from INR 22.81 crore in March 2024 to ...
Read More
Chennai Meenakshi Multispeciality Hospital Stock Surges 40.54% Over Three Months Despite Recent Decline
2025-11-13 09:40:33Chennai Meenakshi Multispeciality Hospital Ltd is experiencing notable buying interest despite recent short-term challenges. While the stock has declined over the past week, its long-term performance remains strong, with significant gains over three, one, three, and five years, indicating a positive growth trajectory in the healthcare sector.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
12-Jan-2026 | Source : BSESub: Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 as amended for the quarter ended 31st December 2025. Based on the confirmation received from Cameo Corporate Services Limited Registrar and Share Transfer Agent of the Company we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within the stipulated time limit under captioned regulations and the details are furnished to the stock exchange.
Appointment of Company Secretary and Compliance Officer
10-Jan-2026 | Source : BSEThis is further to our earlier announcement dated 9th January 2026 relating to the outcome of the Board Meeting held on 9th January 2026 and the appointment of Company Secretary and Compliance Officer pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the appointment of Ms. M.S. Anantha Lakshmi B. Com. C.M.A. M.B.A. A.C.S. C.A. (Inter). (holding Membership No. A46694) as Company Secretary and Compliance Officer of the Company has become effective from 9th January 2026. The details required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD-1/P/CIR/2023/123 dated 13th July 2023 and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024 are provided in Annexure-A.
Appointment of Company Secretary and Compliance Officer
09-Jan-2026 | Source : BSEPursuant to regulation 30 of the SEBI (LODR) Regulations 2015 we wish to inform you that based on the recommendations of Nomination and Remuneration Committee and Audit Committee the board of Directors of the company at its meeting held today i.e. 9th January 2026 has approved the appointment of Ms. M.S. Anantha Lakshmi B. Com M.B.A. ACS. as Company Secretary and Compliance Officer of the Company with effect from 9th January 2026. The details as requested under Regulation 30 read with Schedule III of the SEBI (LODR) Regulations 2015 are provided in the enclosed letter.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available